These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32753638)

  • 1. Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
    D'Andrea S; Berardicurti O; Berardicurti A; Felzani G; Francavilla F; Francavilla S; Giacomelli R; Barbonetti A
    Spinal Cord Ser Cases; 2020 Aug; 6(1):69. PubMed ID: 32753638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
    Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians.
    Attanasi M; Pasini S; Caronni A; Pellegrino GM; Faverio P; Di Pillo S; Cimino MM; Cipolla G; Chiarelli F; Centanni S; Sferrazza Papa GF;
    Respiration; 2020; 99(8):667-677. PubMed ID: 32756065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
    Della-Torre E; Campochiaro C; Cavalli G; De Luca G; Napolitano A; La Marca S; Boffini N; Da Prat V; Di Terlizzi G; Lanzillotta M; Rovere Querini P; Ruggeri A; Landoni G; Tresoldi M; Ciceri F; Zangrillo A; De Cobelli F; Dagna L; ;
    Ann Rheum Dis; 2020 Oct; 79(10):1277-1285. PubMed ID: 32620597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal Visceral Infarction in 3 Patients with COVID-19.
    Besutti G; Bonacini R; Iotti V; Marini G; Riva N; Dolci G; Maiorana M; Spaggiari L; Monelli F; Ligabue G; Guaraldi G; Rossi PG; Pattacini P; Massari M
    Emerg Infect Dis; 2020 Aug; 26(8):1926-1928. PubMed ID: 32396504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
    Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
    BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
    Gómez-Enjuto S; Hernando-Requejo V; Lapeña-Motilva J; Ogando-Durán G; Fouz-Ruiz D; Domingo-García J; Rodríguez-García E; Cemillán-Fernández CA
    Seizure; 2020 Aug; 80():157-158. PubMed ID: 32574838
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
    Valente-Acosta B; Moreno-Sanchez F; Fueyo-Rodriguez O; Palomar-Lever A
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32587121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
    Nuño L; Novella Navarro M; Bonilla G; Franco-Gómez K; Aguado P; Peiteado D; Monjo I; Tornero C; Villalba A; Miranda-Carus ME; De Miguel E; Bogas P; Castilla-Plaza A; Bernad-Pineda M; García-Lorenzo E; Rodríguez-Araya T; Balsa A
    Ann Rheum Dis; 2020 Dec; 79(12):1659-1661. PubMed ID: 32606046
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
    Scarsi M; Piantoni S; Colombo E; Airó P; Richini D; Miclini M; Bertasi V; Bianchi M; Bottone D; Civelli P; Cotelli MS; Damiolini E; Galbassini G; Gatta D; Ghirardelli ML; Magri R; Malamani P; Mendeni M; Molinari S; Morotti A; Salada L; Turla M; Vender A; Tincani A; Brucato A; Franceschini F; Furloni R; Andreoli L
    Ann Rheum Dis; 2020 Oct; 79(10):1286-1289. PubMed ID: 32732245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in Children: Clinical Approach and Management.
    Sankar J; Dhochak N; Kabra SK; Lodha R
    Indian J Pediatr; 2020 Jun; 87(6):433-442. PubMed ID: 32338347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
    Cingolani A; Tummolo AM; Montemurro G; Gremese E; Larosa L; Cipriani MC; Pasciuto G; Liperoti R; Murri R; Pirronti T; Cauda R; Fantoni M;
    Infection; 2020 Oct; 48(5):767-771. PubMed ID: 32642806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis.
    Jones CW; Woodford AL; Platts-Mills TF
    BMJ Open; 2020 Sep; 10(9):e041276. PubMed ID: 32948577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of SARS-CoV-2: How far have we reached?
    Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
    Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
    Danion F; Ruch Y; Fourtage M; Kaeuffer C; Greigert V; Lefebvre N; Muller J; Nai T; Hansmann Y
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513798
    [No Abstract]   [Full Text] [Related]  

  • 19. Two distinct cases with COVID-19 in kidney transplant recipients.
    Kim Y; Kwon O; Paek JH; Park WY; Jin K; Hyun M; Lee JY; Kim HA; Han S
    Am J Transplant; 2020 Aug; 20(8):2269-2275. PubMed ID: 32337859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection.
    Di Perri G
    Infez Med; 2020 Jun; 28(suppl 1):52-56. PubMed ID: 32532939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.